IP Group returned to join corporates BP and Drax for the Leeds CO2 capture spinout’s latest round, taking its total investment in the company to $2.2m since 2009.

PayPal followed an investment in 2017 by participating in a series D round for the cross-border savings platform that will fund geographic expansion.

4Gene is advancing TUM research into exploiting plant-derived glucosides as flexible triggers for releasing flavouring and aromas.

The banking software development platform received series A funding from investors including HSBC and Goldman Sachs, which co-led the round, Banco Sabadell and ANZ.

Orange and Experian have both taken part in a round that will be used to expand the reach of Aire's credit assessment tool in the US.

VetMedUni biopharmaceutical spinout Marinomed Biotech has completed its IPO to attain a market cap of $109m.

Altice has reportedly acquired a 60% share of the live TV streaming service, while existing shareholders such as Sky will retain a stake in the business.

US-based Blue Water Vaccines has an option on University of Oxford research into a universal influenza shot and is looking to raise $15m in funding.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Cambridge-founded automated cell analytics platform Sphere Fluidics has added $2m of funding, bringing its lifetime haul to $14.9m.